Ritual Perimenopause Health Review: Label First
A clean formula with one evidence problem: the label's shatavari dose is one-third of the dose in the perimenopause trial Ritual cites.
| Dose fit | Mismatch: the prominent perimenopause shatavari trial used 300 mg of SRI-81 standardized to more than 10% total shatavarins; Ritual lists 100 mg but does not publicly identify the extract standardization on the label. |
|---|---|
| Evidence fit | One small eight-week perimenopause RCT supports 300 mg SRI-81. No relevant trial of the finished Ritual product was found. No symptom study at the listed 60 mg DIM or 250 mg evening primrose dose was found. |
| Safety flags | Check with a clinician before use if pregnant, breastfeeding, taking hormonal or endocrine therapy, using anticoagulants or antiplatelets, preparing for surgery, or managing a hormone-sensitive condition, epilepsy, schizophrenia or a bleeding disorder. |
| The negative case | The strongest clinical evidence Ritual points to used three times the label's shatavari dose, and the formula has no published finished-product trial. Evening primrose evidence for hot flashes is inconsistent. |
Ritual Perimenopause Health review: the label tells the honest story
When sleep becomes a coin toss and the thermostat drama is real, a tidy capsule is very appealing. The catch is whether its dose matches the research.
Ritual launched Perimenopause Health on September 15, 2026, claiming daily support for mood, sleep, hot flashes, night sweats, dryness and fatigue.
Our take: the four-ingredient formula and quality marks are appealing. The evidence match is not. The key shatavari study used 300 mg of a standardized extract; Ritual lists 100 mg.
The claim, attributed
In its launch announcement, Ritual said the product has no added synthetic hormones and was developed with doctors on its Scientific Advisory Board. The company says its shatavari extract was studied in perimenopausal women and links the launch to improvements in mood, sleep, hot flashes, night sweats, vaginal dryness and fatigue over four to eight weeks.
Those are supplement claims, not proof that this finished product works. Ritual’s release also says the FDA has not evaluated them.
What is in one capsule?
Ritual’s live listing and indexed Supplement Facts show:
| Ingredient | Amount per day | Missing or notable detail |
|---|---|---|
| Shatavari root extract | 100 mg | Extract ratio and shatavarin percentage were not visible in the public text we could verify |
| DIM | 60 mg | The public panel does not name an enhanced source |
| Vitamin B6 | 0.9 mg | P5P form; 50% of the US Daily Value |
| Evening primrose seed oil | 250 mg | Gamma-linolenic acid amount is not listed |
The bottle has 30 vegan capsules. Ritual says it is NSF Certified, Non-GMO Project Verified, Clean Label Project Purity Award-certified, vegan, gluten-free and soy-free. Those marks speak to manufacturing standards, not clinical efficacy.
The negative case first
There is no published trial of Ritual Perimenopause Health itself. We found no independent hands-on review or robust long-term study of the finished product.
The best-aligned trial cited in Ritual’s launch used 300 mg of SRI-81 shatavari root extract daily for eight weeks, not 100 mg. It was a 13:1 extract standardized to more than 10% total shatavarins by HPLC. Eighty perimenopausal women were randomized and 73 completed the protocol. The extract group improved more than placebo on a symptom scale and hot-flash frequency, but the study was short, single-site and tested shatavari alone.
Ritual says its extract is highly concentrated, so 100 mg can provide the studied amount of active compounds. That is plausible. It only transfers if the standardization is verified. The exact extract identity and shatavarin amount are the missing receipt.
What the evidence says
Shatavari. The 2025 randomized study was a real signal. Compared with placebo, 300 mg SRI-81 improved total symptom scores, perceived stress and hot-flash frequency. But placebo also improved, several quality-of-life domains did not differ significantly, and the authors called for longer, larger trials. No relevant study establishes the same benefit at Ritual’s listed 100 mg dose.
DIM. Human studies show DIM can change estrogen-metabolite patterns. That is not the same as fewer hot flashes or better sleep. We found no relevant study showing symptom benefit from 60 mg DIM in perimenopausal women. Memorial Sloan Kettering notes a tamoxifen study that found lower endoxifen levels with DIM.
Evening primrose oil. Ritual says it can ease hot flashes and support DIM absorption. The symptom evidence is mixed. A 2025 systematic review found insufficient evidence, with no significant improvement in hot-flash frequency or duration. Trials often used at least 1,000 mg. Ritual lists 250 mg without the GLA amount.
Vitamin B6. The 0.9 mg amount is below the US adult RDA of 1.3 mg for women ages 19 to 50. We found no study showing that it improves perimenopausal mood. The NIH Office of Dietary Supplements notes interactions with some medicines.
Who should ask a clinician first
This is a label-and-evidence review, not medical advice.
- Hormone-sensitive history or hormonal medicines: Evening primrose oil may have estrogen-like effects, and DIM can alter hormone metabolism. This includes people taking tamoxifen or fertility treatment.
- Pregnancy, trying to conceive, or breastfeeding: We found no basis for assuming this blend is appropriate.
- Blood thinners, antiplatelets or upcoming surgery: Mayo Clinic warns about bleeding risk and says to stop evening primrose two weeks before surgery.
- Epilepsy or schizophrenia: Mayo Clinic warns about seizure risk.
The real cost
The launch price is $39 for 30 capsules, or $1.30 a day and about $468 yearly.
The live Ritual collection page showed a temporary $31.20 sale price when checked: $1.04 per day, or about $374.40 annually. Promotions can change.
If hot flashes, sleep or night sweats are the main problem, you are also paying for DIM, B6 and evening primrose oil alongside a shatavari extract not shown at 100 mg in a perimenopause trial.
What we still do not know
The public panel does not state the extract ratio or total shatavarins. We could not independently verify that Ritual uses the studied extract. No trial shows the blend beats shatavari alone, and long-term usefulness is unknown because the product is new.
For a buyer who values short labels and verified quality marks, this is a clean product to watch. It is not yet a label-and-evidence match for its biggest headline. Ask Ritual which shatavari extract it uses, how much total shatavarin it provides, and whether a study exists at 100 mg.
Price-check disclosure
PeriProof has no affiliate relationship with Ritual and received no product for this review. The retailer link is a price check, not a sponsored recommendation. Check the current Ritual price before purchase.